Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2018

Open Access 01-12-2018 | Research article

Assessing the effect of risk factors on rates of obstetric transfusion over time using two methodological approaches

Authors: Edward Jegasothy, Jillian Patterson, Deborah Randall, Tanya A. Nippita, Judy M. Simpson, David O. Irving, Jane B. Ford

Published in: BMC Medical Research Methodology | Issue 1/2018

Login to get access

Abstract

Background

While red blood cell transfusion rates have declined in most Australian medical specialties, obstetric transfusion rates have instead been increasing. Obstetric transfusions are mostly linked to postpartum haemorrhage, the rates of which have also increased over time. This study used two methodological approaches to investigate recent trends in obstetric transfusion in New South Wales (NSW) and the extent to which this was influenced by changing maternal and pregnancy characteristics.

Methods

Linked birth and hospital records were used to examine rates of red blood cell transfusion in the postpartum period for mothers giving birth in NSW hospitals from 2005 to 2015. Logistic regression models were run to examine the contribution of maternal and pregnancy risk factors to changing rates of transfusion. Risk factors were divided into “pre-pregnancy” and “pregnancy related”. Crude and adjusted estimates of the effect of year of birth on obstetric transfusion rates were compared to assess the effect of risk factors on rates over time using two approaches. The first compared actual and predicted odds ratios of transfusion for each year. The second compared the observed increase in transfusion rate with that predicted after controlling for the risk factors.

Results

Among 935,659 births, the rate of obstetric transfusion rose from 13 per 1000 births in 2005 to 17 in 2011, and remained stable until 2015. From 2005 to 2015, postpartum haemorrhage increased from 74 to 114 per 1000 births. Compared with the rate in 2005, the available maternal and pregnancy characteristics only partially explained the change in rate of transfusion by 2015 (Method 1, crude odds ratio 1.39 (95% CI 1.25, 1.56); adjusted odds ratio 1.29 (95% CI 1.15, 1.45)). After adjustment for maternal and pregnancy characteristics, obstetric transfusion incidence was predicted to increase by 10.3%, but a 38.7% increase was observed (Method 2).

Conclusion

Rates of obstetric transfusion have stabilised after a period of increase. The trend could not be fully explained by measured maternal and pregnancy characteristics with either of the two approaches. Further investigation of rates and maternal and clinical risk factors will help to inform and improve obstetric blood product use.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shander A, Isbister J, Gombotz H. Patient blood management: the global view. Transfusion. 2016;56(Suppl 1):S94–102.CrossRef Shander A, Isbister J, Gombotz H. Patient blood management: the global view. Transfusion. 2016;56(Suppl 1):S94–102.CrossRef
2.
go back to reference NBA: National Blood Authority Annu Rep 2013–14. In. Canberra, Australia: National Blood Authority; 2014. NBA: National Blood Authority Annu Rep 2013–14. In. Canberra, Australia: National Blood Authority; 2014.
3.
go back to reference Patterson JA, Roberts CL, Bowen JR, Irving DO, Isbister JP, Morris JM, Ford JB. Blood transfusion during pregnancy, birth, and the postnatal period. Obstet Gynecol. 2014;123(1):126–33.CrossRef Patterson JA, Roberts CL, Bowen JR, Irving DO, Isbister JP, Morris JM, Ford JB. Blood transfusion during pregnancy, birth, and the postnatal period. Obstet Gynecol. 2014;123(1):126–33.CrossRef
4.
go back to reference Shortt J, Polizzotto MN, Waters N, Borosak M, Moran M, Comande M, Devine A, Jolley DJ, Wood EM. Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the bloodhound prospective audit of red blood cell use. Transfusion. 2009;49(11):2296–303.CrossRef Shortt J, Polizzotto MN, Waters N, Borosak M, Moran M, Comande M, Devine A, Jolley DJ, Wood EM. Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the bloodhound prospective audit of red blood cell use. Transfusion. 2009;49(11):2296–303.CrossRef
5.
go back to reference NBA: Patient Blood Management Guidelines: Module 5 - Obstetrics and Maternity. In. Canberra, Australia: National Blood Authority; 2015. NBA: Patient Blood Management Guidelines: Module 5 - Obstetrics and Maternity. In. Canberra, Australia: National Blood Authority; 2015.
6.
go back to reference NBA: Patient Blood Management Guidelines: Module 1 - Critical Bleeding / Massive Transfusion. In. Canberra, Australia: National Blood Authority; 2011. NBA: Patient Blood Management Guidelines: Module 1 - Critical Bleeding / Massive Transfusion. In. Canberra, Australia: National Blood Authority; 2011.
7.
go back to reference Mayson E, Shand AW, Ford JB. Single-unit transfusions in the obstetric setting: a qualitative study. Transfusion. 2016;56(7):1716–22.CrossRef Mayson E, Shand AW, Ford JB. Single-unit transfusions in the obstetric setting: a qualitative study. Transfusion. 2016;56(7):1716–22.CrossRef
8.
go back to reference Ford JB, Patterson JA, Seeho SK, Roberts CL. Trends and outcomes of postpartum haemorrhage, 2003-2011. BMC pregnancy and childbirth. 2015;15:334.CrossRef Ford JB, Patterson JA, Seeho SK, Roberts CL. Trends and outcomes of postpartum haemorrhage, 2003-2011. BMC pregnancy and childbirth. 2015;15:334.CrossRef
9.
go back to reference AIHW: Australia's mothers and babies 2014—in brief. In. Canberra: AIHW; 2016. AIHW: Australia's mothers and babies 2014—in brief. In. Canberra: AIHW; 2016.
10.
go back to reference Centre for Health Record Linkage: Master Linkage Key Qual Assur In.; 2012. Centre for Health Record Linkage: Master Linkage Key Qual Assur In.; 2012.
11.
go back to reference Patterson JA, Roberts CL, Isbister JP, Irving DO, Nicholl MC, Morris JM, Ford JB. What factors contribute to hospital variation in obstetric transfusion rates? Vox Sang. 2015;108(1):37–45.CrossRef Patterson JA, Roberts CL, Isbister JP, Irving DO, Nicholl MC, Morris JM, Ford JB. What factors contribute to hospital variation in obstetric transfusion rates? Vox Sang. 2015;108(1):37–45.CrossRef
12.
go back to reference Nyflot LT, Sandven I, Stray-Pedersen B, Pettersen S, Al-Zirqi I, Rosenberg M, Jacobsen AF, Vangen S. Risk factors for severe postpartum hemorrhage: a case-control study. BMC pregnancy and childbirth. 2017;17(1):17.CrossRef Nyflot LT, Sandven I, Stray-Pedersen B, Pettersen S, Al-Zirqi I, Rosenberg M, Jacobsen AF, Vangen S. Risk factors for severe postpartum hemorrhage: a case-control study. BMC pregnancy and childbirth. 2017;17(1):17.CrossRef
13.
go back to reference Wikkelso AJ, Hjortoe S, Gerds TA, Moller AM, Langhoff-Roos J. Prediction of postpartum blood transfusion--risk factors and recurrence. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2014;27(16):1661–7.CrossRef Wikkelso AJ, Hjortoe S, Gerds TA, Moller AM, Langhoff-Roos J. Prediction of postpartum blood transfusion--risk factors and recurrence. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2014;27(16):1661–7.CrossRef
14.
go back to reference Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, Joseph KS. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(5):449.e1–7.CrossRef Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, Joseph KS. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(5):449.e1–7.CrossRef
15.
go back to reference Mehrabadi A, Liu S, Bartholomew S, Hutcheon JA, Kramer MS, Liston RM, Joseph KS. Temporal trends in postpartum hemorrhage and severe postpartum hemorrhage in Canada from 2003 to 2010. J Obstet Gynaecol Can. 2014;36(1):21–33.CrossRef Mehrabadi A, Liu S, Bartholomew S, Hutcheon JA, Kramer MS, Liston RM, Joseph KS. Temporal trends in postpartum hemorrhage and severe postpartum hemorrhage in Canada from 2003 to 2010. J Obstet Gynaecol Can. 2014;36(1):21–33.CrossRef
16.
go back to reference Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. The Cochrane database of systematic reviews. 2014;2:CD003249. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. The Cochrane database of systematic reviews. 2014;2:CD003249.
17.
go back to reference Lain SJ, Roberts CL, Hadfield RM, Bell JC, Morris JM. How accurate is the reporting of obstetric haemorrhage in hospital discharge data? A validation study. Aust N Z J Obstet Gynaecol. 2008;48(5):481–4.CrossRef Lain SJ, Roberts CL, Hadfield RM, Bell JC, Morris JM. How accurate is the reporting of obstetric haemorrhage in hospital discharge data? A validation study. Aust N Z J Obstet Gynaecol. 2008;48(5):481–4.CrossRef
18.
go back to reference Patterson JA, Roberts CL, Taylor LK, Ford JB. Reporting postpartum haemorrhage with transfusion: a comparison of NSW birth and hospital data. New South Wales Public Health Bulletin. 2014;24(4):153–8.PubMed Patterson JA, Roberts CL, Taylor LK, Ford JB. Reporting postpartum haemorrhage with transfusion: a comparison of NSW birth and hospital data. New South Wales Public Health Bulletin. 2014;24(4):153–8.PubMed
19.
go back to reference Roberts CL, Algert CS, Ford JB. Methods for dealing with discrepant records in linked population health datasets: a cross-sectional study. BMC Health Serv Res. 2007;7(1):12.CrossRef Roberts CL, Algert CS, Ford JB. Methods for dealing with discrepant records in linked population health datasets: a cross-sectional study. BMC Health Serv Res. 2007;7(1):12.CrossRef
21.
go back to reference Merriam AA, Wright JD, Siddiq Z, D'Alton ME, Friedman AM, Ananth CV, Bateman BT. Risk for postpartum hemorrhage, transfusion, and hemorrhage-related morbidity at low, moderate, and high volume hospitals. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2017:1–10. Merriam AA, Wright JD, Siddiq Z, D'Alton ME, Friedman AM, Ananth CV, Bateman BT. Risk for postpartum hemorrhage, transfusion, and hemorrhage-related morbidity at low, moderate, and high volume hospitals. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2017:1–10.
22.
go back to reference van Stralen G, von Schmidt Auf Altenstadt JF, Bloemenkamp KW, van Roosmalen J, Hukkelhoven CW. Increasing incidence of postpartum hemorrhage: the Dutch piece of the puzzle. Acta Obstet Gynecol Scand. 2016;95(10):1104–10.CrossRef van Stralen G, von Schmidt Auf Altenstadt JF, Bloemenkamp KW, van Roosmalen J, Hukkelhoven CW. Increasing incidence of postpartum hemorrhage: the Dutch piece of the puzzle. Acta Obstet Gynecol Scand. 2016;95(10):1104–10.CrossRef
23.
go back to reference Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368–73.CrossRef Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368–73.CrossRef
24.
go back to reference Therapeutic Goods Administration: Australian Public Assessment Report for Tranexamic acid. In. ACT, Australia; 2010. Therapeutic Goods Administration: Australian Public Assessment Report for Tranexamic acid. In. ACT, Australia; 2010.
25.
go back to reference Heesen M, Bohmer J, Klohr S, Rossaint R, van de Velde M, Dudenhausen JW, Straube S. Prophylactic tranexamic acid in parturients at low risk for post-partum haemorrhage: systematic review and meta-analysis. Acta Anaesthesiol Scand. 2014;58(9):1075–85.CrossRef Heesen M, Bohmer J, Klohr S, Rossaint R, van de Velde M, Dudenhausen JW, Straube S. Prophylactic tranexamic acid in parturients at low risk for post-partum haemorrhage: systematic review and meta-analysis. Acta Anaesthesiol Scand. 2014;58(9):1075–85.CrossRef
26.
go back to reference Sentilhes L, Lasocki S, Ducloy-Bouthors AS, Deruelle P, Dreyfus M, Perrotin F, Goffinet F, Deneux-Tharaux C. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth. 2015;114(4):576–87.CrossRef Sentilhes L, Lasocki S, Ducloy-Bouthors AS, Deruelle P, Dreyfus M, Perrotin F, Goffinet F, Deneux-Tharaux C. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth. 2015;114(4):576–87.CrossRef
27.
go back to reference Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi. 2001;36(10):590–2.PubMed Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi. 2001;36(10):590–2.PubMed
28.
go back to reference Ducloy-Bouthors A-S, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15(2):R117.CrossRef Ducloy-Bouthors A-S, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15(2):R117.CrossRef
29.
go back to reference World Health Organisation (WHO). Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage. Switzerland: WHO; 2017. World Health Organisation (WHO). Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage. Switzerland: WHO; 2017.
30.
go back to reference World Health Organisation (WHO): WHO Recommendations for the Prevention and of Postpartum Haemorrhage. In. Switzerland: WHO; 2012. World Health Organisation (WHO): WHO Recommendations for the Prevention and of Postpartum Haemorrhage. In. Switzerland: WHO; 2012.
31.
go back to reference Miller S, Burke T, Belizán JM, Fuchtner C, Lalonde A, Malhorta J. Tranexamic acid for post-partum haemorrhage in the WOMAN trial. Lancet. 2017;390(10102):1583.CrossRef Miller S, Burke T, Belizán JM, Fuchtner C, Lalonde A, Malhorta J. Tranexamic acid for post-partum haemorrhage in the WOMAN trial. Lancet. 2017;390(10102):1583.CrossRef
32.
go back to reference Abdul-Kadir R, McLintock C, Ducloy AS, El-Refaey H, England A, Federici AB, Grotegut CA, Halimeh S, Herman JH, Hofer S, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014;54(7):1756–68.CrossRef Abdul-Kadir R, McLintock C, Ducloy AS, El-Refaey H, England A, Federici AB, Grotegut CA, Halimeh S, Herman JH, Hofer S, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014;54(7):1756–68.CrossRef
33.
go back to reference Zatta A, McQuilten Z, Kandane-Rathnayake R, Isbister J, Dunkley S, McNeil J, Cameron P, Phillips L. The Australian and New Zealand Haemostasis registry: ten years of data on off-licence use of recombinant activated factor VII. Blood transfusion = Trasfusione del sangue. 2015;13(1):86–99.PubMedPubMedCentral Zatta A, McQuilten Z, Kandane-Rathnayake R, Isbister J, Dunkley S, McNeil J, Cameron P, Phillips L. The Australian and New Zealand Haemostasis registry: ten years of data on off-licence use of recombinant activated factor VII. Blood transfusion = Trasfusione del sangue. 2015;13(1):86–99.PubMedPubMedCentral
34.
go back to reference Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):267–78.CrossRef Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):267–78.CrossRef
35.
go back to reference Mayson E, Ampt AJ, Shand AW, Ford JB. Intravenous iron: barriers and facilitators to its use at nine maternity hospitals in New South Wales, Australia. The Australian & New Zealand journal of obstetrics & gynaecology. 2016;56(2):162–72.CrossRef Mayson E, Ampt AJ, Shand AW, Ford JB. Intravenous iron: barriers and facilitators to its use at nine maternity hospitals in New South Wales, Australia. The Australian & New Zealand journal of obstetrics & gynaecology. 2016;56(2):162–72.CrossRef
Metadata
Title
Assessing the effect of risk factors on rates of obstetric transfusion over time using two methodological approaches
Authors
Edward Jegasothy
Jillian Patterson
Deborah Randall
Tanya A. Nippita
Judy M. Simpson
David O. Irving
Jane B. Ford
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2018
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-018-0595-6

Other articles of this Issue 1/2018

BMC Medical Research Methodology 1/2018 Go to the issue